The entry into force of the European regulation on health technology assessment marks the start of a new era. It heralds greater cooperation between agencies responsible for these assessments in different European states, the aim being to facilitate access to innovations with a clinical benefit, in the interest of patients. How can this objective be met without departing from the stringent quality, safety and transparency standards required for any health technology assessment? What are the factors for success, both in times of crisis and in the long term?
This international, participa...
